Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Newleos Therapeutics in the transaction. Newleos Therapeutics, a clinical stage neuroscience company co-founded by Longwood Fund and seasoned...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Photys Therapeutics in the transaction. Photys Therapeutics (Photys), a proximity-based therapeutics company, announced its multi-year collaboration and license...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Lightmatter in the transaction. Lightmatter, a leader in photonic supercomputing, announced raising $400 million in Series D financing...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Brixton Biosciences in the transaction. Brixton Biosciences, a clinical stage life sciences company, announced it has raised $33...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Reshape Biotech in the transaction. Reshape Biotech, a robotic technology developer, announced it raised its $20 million in...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Prepared in the transaction. Prepared announced its $16 million Series A financing led by Andreessen Horowitz, and included the...
You must be a Standard 1 Year member to access this content.
